Tudor Investment Corp ET AL Increases Stock Position in Sotera Health (NASDAQ:SHC)

Tudor Investment Corp ET AL raised its holdings in shares of Sotera Health (NASDAQ:SHC - Free Report) by 14.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 818,691 shares of the company's stock after acquiring an additional 101,272 shares during the quarter. Tudor Investment Corp ET AL owned approximately 0.29% of Sotera Health worth $11,200,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the business. Blue Trust Inc. boosted its holdings in Sotera Health by 164.3% in the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after purchasing an additional 1,140 shares in the last quarter. Quarry LP acquired a new position in shares of Sotera Health in the 4th quarter valued at $28,000. GAMMA Investing LLC boosted its holdings in shares of Sotera Health by 37.5% in the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock valued at $56,000 after buying an additional 1,121 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in Sotera Health by 37.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after acquiring an additional 1,640 shares in the last quarter. Finally, Sterling Capital Management LLC raised its stake in Sotera Health by 58.5% during the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock worth $124,000 after acquiring an additional 3,331 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Stock Performance

Shares of NASDAQ:SHC traded up $0.28 on Friday, reaching $12.38. The company's stock had a trading volume of 1,075,697 shares, compared to its average volume of 1,205,400. Sotera Health has a 52-week low of $9.53 and a 52-week high of $17.08. The stock has a market capitalization of $3.51 billion, a P/E ratio of 49.52 and a beta of 1.88. The stock's 50-day moving average is $11.38 and its two-hundred day moving average is $13.01. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.12 by $0.02. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm had revenue of $254.52 million during the quarter, compared to the consensus estimate of $245.56 million. During the same period in the prior year, the business earned $0.13 EPS. The firm's revenue was up 2.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Sotera Health will post 0.61 EPS for the current year.

Wall Street Analyst Weigh In

SHC has been the topic of several research reports. Piper Sandler dropped their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. Barclays dropped their price target on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Sotera Health presently has a consensus rating of "Moderate Buy" and an average target price of $15.20.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.